Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) currently has a daily average trading volume of 4.46M but it saw 3752462 shares traded in last market. With a market cap of 2.18B USD, the company’s current market price of $10.40 came falling about -1.98 while comparing to the previous closing price of $10.61. In past 52 weeks, the stock remained buoying in the range of price level as high as $11.31 and as low as $5.92. In the recent trading on the day, stock has struck highest price mark of $10.34 while lowest mark touched by it was $10.64.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Cantor Fitzgerald which initiated the stock as “Overweight” in its note to investors issued on April 29, 2025, recommending a price target of $20 for it. JP Morgan issued its recommendations for the stock as it resumed the price target for the stock is $10.
Over the week, BCRX’s stock price is moving -5.28% down while it is 3.38% when we observe its performance for the past one month. Year-to-date it is 38.30% up and over the past year, the stock is showing an upside performance of 59.51%.
Currently, Biocryst Pharmaceuticals Inc’s total number of outstanding shares is 209.21M with 1.15% of that held by the insiders while 85.57% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -15.72%. It has a 26.43 of forward P/E ratio. Stock’s beta reads 1.10. Stock has a price to sale or P/S ratio amounts to 4.32. Its return on asset (ROA) is -11.28% on average.
